Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Proud Amneal Offers Preview Of Q1 Growth
Preliminary Figures Show Sales Up 12%, Adjusted EBITDA Up 18% In First Quarter Of 2023
Apr 19 2023
•
By
David Wallace
Amneal has indicated double-digit growth in the first quarter • Source: Shutterstock
More from Earnings
More from Business